Perioperative outcomes of esophagectomy after doublet versus docetaxel‐based triplet neoadjuvant chemotherapy in older patients: A nationwide inpatient database study in Japan
Neoadjuvant DCF was not associated with a higher frequency of perioperative adverse events compared with CF after esophagectomy in patients aged 70-79 years.
Authors
- Hidehiro Kaneko (ORCID: https://orcid.org/0000-0003-2553-6170)
- Hiroki Matsui (ORCID: https://orcid.org/0000-0003-0004-4743)
- Yuki Hirano (ORCID: https://orcid.org/0000-0002-3976-2278)
- Hirofumi Kawakubo (ORCID: https://orcid.org/0000-0002-4929-5482)
- Yuya Kimura (ORCID: https://orcid.org/0000-0003-1649-0596)
- Satoru Matsuda (ORCID: https://orcid.org/0000-0001-8441-2755)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Osamu Itano (ORCID: https://orcid.org/0000-0002-2197-9508)
- Takaaki Konishi (ORCID: https://orcid.org/0000-0002-9538-4419)
- Hiroyuki Daiko (ORCID: https://orcid.org/0000-0002-9562-2966)
- Yuko Kitagawa (ORCID: https://orcid.org/0000-0002-0271-5670)
- Kiyohide Fushimi (ORCID: https://orcid.org/0000-0002-1894-0290)
Institutions
- Tokyo Medical and Dental University (JP)
- Keio University (JP)
- University of Tokyo Health Sciences (JP)
- The University of Tokyo (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Annals of Gastroenterological Surgery
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1002/ags3.70000
- Citations
- 2
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Pfizer
- Takeda Pharmaceutical Company
- Ministry of Health, Labour and Welfare